Bioprocessing

Modern industrial sectors are witnessing a quiet revolution where microscopic organisms are replacing heavy machinery and toxic solvents in the race for cleaner and more efficient production. Industrial bioprocessing allows for the creation of complex medicines derived from living organisms,

Personalized medicine is emerging as a primary catalyst for manufacturing innovation, requiring flexible platforms that can efficiently produce high-yield therapies for smaller patient populations. This fundamental shift marks the end of the traditional era where massive, stainless-steel vats

The pursuit of engineering non-standard proteins has reached a significant milestone with the development of a system that reassigns sense codons on a massive scale. At the Wyss Institute for Biologically Inspired Engineering, a research group led by George Church has unveiled AGENTEX, a platform

Feed concentrates are becoming increasingly vital for large-scale bioreactor operations where nutrients must be replenished without diluting the existing cell culture. This fundamental shift in bioprocessing technology underscores a much larger movement within the global food system, which is

The medical landscape is currently grappling with a profound paradox as the most promising frontier in immunology faces an unprecedented crisis of confidence. The biopharmaceutical sector must now determine if the high levels of toxicity tolerated in oncology are an acceptable trade-off for

Industrial biomanufacturing efficiency is often compromised because the behavior of a cell population can change significantly from the early phase to high-density growth. This phenomenon creates a fundamental disconnect between the highly controlled blueprints of synthetic biology and the messy,